InsidersTradesSigma
Track the 黄山胶囊 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 黄山胶囊 has logged 1 insider filings. Market capitalisation: €1.8bn. The latest transaction was filed on 30 June 2025 (Sale). Among the most active insiders: 叶松林. All data is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€375,804
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 9,782 of 29,064 companies
59.7
score / 100
Value52
Quality67
FCF yld4.5%
Earn yld3.6%
EV/EBITDA14.8x
ROE6.6%
Gross mgn30%
Net mgn14%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2025
关于 黄山胶囊
黄山胶囊是一家专注于生产包括胶囊和草药在内的医药产品的公司。该公司在XSHE市场上市。